Showing results (181-190 of 219) with videos related to
Sort By:
Pageof 22
Rheumatology (Oxford, England)|July 28, 2023
Development and testing of a bespoke cultural intervention to support healthcare professionals with patients from a diverse backgroundAshwini Deshmukh, Lisa Roberts, Adewale Adebajo, et al.BMJ Open|October 21, 2025
Understanding internet-supported self-management for low back pain in primary care: a qualitative process evaluation of the SupportBack 2 randomised controlled trialAdam W A Geraghty, Stephanie Hughes, Lisa Roberts, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2004
Apoptosis-inducing signal sequence mutation in carbonic anhydrase IV identified in patients with the RP17 form of retinitis pigmentosaGeorge Rebello, Rajkumar Ramesar, Alvera Vorster, et al.JMIR Aging|March 15, 2023
Developing a Memory and Communication App for Persons Living With Dementia: An 8-Step ProcessEllen L Brown, Nicole Ruggiano, Sai Chaithra Allala, et al.The International Journal of Biological Markers|May 1, 2009
Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapyRaquel A Nunes, Xiaochun Li, Soonmo Peter Kang, et al.Research in Gerontological Nursing|September 20, 2021
Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care: Intervention TrialEllen L Brown, Nicole Ruggiano, Lisa Roberts, et al.Journal of Medical Internet Research|May 16, 2021
Clinical Outcomes of Asynchronous Versus Synchronous Telepsychiatry in Primary Care: Randomized Controlled TrialPeter M Yellowlees, Michelle Burke Parish, Alvaro D Gonzalez, et al.Molecular Cancer Therapeutics|May 28, 2015
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule InhibitorYu Xiao, Paul Nimmer, George S Sheppard, et al.Acta Oncologica (Stockholm, Sweden)|November 19, 2025
Prevalence, molecular characterization, and prognosis of c-Met protein overexpression in a real-world cohort of patients with non-squamous non-small cell lung cancerJair Bar, Mona H Cai, Yookyung Christy Choi, et al.Investigational New Drugs|March 20, 2020
A phase 1 study evaluating safety and pharmacokinetics of losatuxizumab vedotin (ABBV-221), an anti-EGFR antibody-drug conjugate carrying monomethyl auristatin E, in patients with solid tumors likely to overexpress EGFRJames M Cleary, Emiliano Calvo, Victor Moreno, et al.Pageof 22